<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 27 year old woman presented with recurrent cerebrovascular <z:hpo ids='HP_0001297'>strokes</z:hpo> in the setting of an ill defined auto-<z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immune disease</z:e> responsive to <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> therapy </plain></SENT>
<SENT sid="1" pm="."><plain>Investigation for a <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> revealed activated protein C resistance in the absence of protein C, protein S, or <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> or anticardiolipin antibodies </plain></SENT>
<SENT sid="2" pm="."><plain>Her parents and sibling did not demonstrate APC resistance </plain></SENT>
<SENT sid="3" pm="."><plain>This case suggests that activated protein C resistance may be associated with arterial as well as venous thrombotic events and implies that resistance to activated protein C should also be considered in the evaluation of young adults with <z:hpo ids='HP_0001297'>strokes</z:hpo> </plain></SENT>
</text></document>